Oral contraceptive use and the risk of inflammatory bowel disease

  • University of North Carolina at Chapel Hill ROR

Epidemiology (Cambridge, Mass.), 3(4), 374-378

DOI 10.1097/00001648-199207000-00014 PMID 1637902

Abstract

We used rosters of the Crohn's and Colitis Foundation of America to identify potential cases and peer-nominated controls to explore the reported association between oral contraceptives and inflammatory bowel disease. Overall, women who used oral contraceptives were at increased risk of developing Crohn's disease (odds ratio = 1.49, 95% confidence interval (CI) = 0.99-2.26). The findings persisted after adjustment for age at symptom onset, decade of onset, education, marital status, and location of disease. There was an interaction with cigarette smoking; the risk associated with oral contraceptives was elevated in current smokers (odds ratio = 2.64, 95% CI = 1.22-5.75), but not in former smokers or never-smokers. The risk was not elevated for ulcerative colitis (odds ratio = 1.10, 95% CI = 0.65-1.85).

Topics

oral contraceptive inflammatory bowel disease risk, birth control pill Crohn's disease association, oral contraceptives Crohn's disease cigarette smoking interaction, hormonal contraception IBD epidemiology case control, oral contraceptive use ulcerative colitis risk, combined oral contraceptive autoimmune disease risk, contraceptive side effects gastrointestinal disease, oral contraceptives Crohn's disease odds ratio smoking, hormonal contraception inflammatory bowel disease epidemiology, pill use chronic inflammatory disease risk factors
PMID 1637902 1637902 DOI 10.1097/00001648-199207000-00014 10.1097/00001648-199207000-00014

Cite this article

Sandler, R., Wurzelmann, J. I., & Lyles, C. (1992). Oral contraceptive use and the risk of inflammatory bowel disease. *Epidemiology (Cambridge, Mass.)*, *3*(4), 374-378. https://doi.org/10.1097/00001648-199207000-00014

Related articles